A11S (p.Ala11Ser) variant of B2M (Beta-2-microglobulin)

A11S (p.Ala11Ser) in B2M (Beta-2-microglobulin) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance in the context of in IMD43. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes population frequency data and structural context.

A11S (p.Ala11Ser) variant details